Monday, March 10, 2025 | 04:01 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Page 13 - Vaccination

6 months post second dose ideal for booster: Bharat Biotech's Krishna Ella

The ideal time for a booster dose for COVID-19 vaccine is six months after the second dose, Bharat Biotech Chairman and Managing Director Krishna Ella said

6 months post second dose ideal for booster: Bharat Biotech's Krishna Ella
Updated On : 10 Nov 2021 | 11:06 PM IST

96 nations have agreed to mutual recognition of vax certificates: Minister

Ninety-six countries have agreed to mutual recognition of COVID-19 vaccination certificates with India, Union Health Minister Mansukh Mandaviya said on Tuesday.

96 nations have agreed to mutual recognition of vax certificates: Minister
Updated On : 09 Nov 2021 | 10:51 PM IST

Lessons from Europe

India must speed up vaccination

Lessons from Europe
Updated On : 08 Nov 2021 | 10:27 PM IST

SC to hear plea seeking disclosure of data on Covid shots' trials on Nov 29

The apex court had earlier in August asked the Centre, Bharat Biotech, SII, and others to respond to the plea which sought directions to also disclose post-vaccination data regarding adverse events

SC to hear plea seeking disclosure of data on Covid shots' trials on Nov 29
Updated On : 08 Nov 2021 | 7:57 PM IST

Pfizer, Astra shots generate more antibodies than natural infection: Study

People who receive the Pfizer or AstraZeneca COVID-19 vaccine have antibody levels significantly higher than those infected with the SARS-CoV-2 virus, according to a study

Pfizer, Astra shots generate more antibodies than natural infection: Study
Updated On : 08 Nov 2021 | 7:36 PM IST

German Covid-19 infection rate at new high as vaccinations slow

Germany's coronavirus infection rate climbed to its highest recorded level yet on Monday as what officials have called a pandemic of the unvaccinated gathers pace

German Covid-19 infection rate at new high as vaccinations slow
Updated On : 08 Nov 2021 | 2:45 PM IST

With curbs lifted, fully vaccinated passengers from India take to US skies

The coronavirus pandemic had prompted the US to close its borders to international travellers from many countries, including India, last year

With curbs lifted, fully vaccinated passengers from India take to US skies
Updated On : 08 Nov 2021 | 2:37 PM IST

Covid-19 vaccination success to be BJP's mantra before assembly polls

Party passes resolution saying it would achieve victory in all forthcoming state elections

Covid-19 vaccination success to be BJP's mantra before assembly polls
Updated On : 07 Nov 2021 | 11:31 PM IST

Explained: What it takes to run child trials for a Covid-19 vaccine

JAB AT HAND: From encouraging people to volunteer to screening kids and winning their confidence

Explained: What it takes to run child trials for a Covid-19 vaccine
Updated On : 08 Nov 2021 | 6:04 AM IST

More than 1.16 bn Covid-19 vaccine doses provided to states/UTs: Centre

More than 116.50 crore Covid vaccine doses have been provided to states and Union territories so far through the Centre and direct state procurement category, the Union health ministry said on Friday.

More than 1.16 bn Covid-19 vaccine doses provided to states/UTs: Centre
Updated On : 05 Nov 2021 | 4:49 PM IST

Over 150 mn vaccine doses still available with states: Health Ministry

More than 15.54 crore balance and unutilized Covid-19 vaccine doses are still available with the states and UTs to be administered, said Union Health Ministry on Friday

Over 150 mn vaccine doses still available with states: Health Ministry
Updated On : 05 Nov 2021 | 4:12 PM IST

Novavax files for emergency use listing of Covid-19 vaccine with WHO

Biotechnology firm Novavax Inc said it has completed the rolling submission for the emergency use listing (EUL) of its COVID-19 vaccine candidate to the World Health Organization (WHO). Earlier on Monday, Novavax and its partner Serum Institute of India (SII) had said that they had received the first emergency use authorisation (EUA) for COVID-19 vaccine in Indonesia. "The company has now completed the submission to World Health Organization (WHO) of all modules required for the regulatory evaluation of NVX-CoV2373, the company's recombinant nanoparticle protein-based COVID-19 vaccine with Matrix-M adjuvant," Novavax Inc said in a statement on Thursday. The chemistry, manufacturing and controls module submitted to WHO, as well as other regulatory agencies worldwide, leverages Novavax' manufacturing partnership with the SII, the world's largest vaccine manufacturer by volume, it added. Novavax will make further submissions to enable vaccine supply from additional manufacturing sites

Novavax files for emergency use listing of Covid-19 vaccine with WHO
Updated On : 05 Nov 2021 | 3:43 PM IST

Bharat Biotech's Covaxin set to go global after WHO gives it a booster

Becomes sixth vaccine to receive validation; move will ease foreign travel for those who got jab

Bharat Biotech's Covaxin set to go global after WHO gives it a booster
Updated On : 04 Nov 2021 | 12:03 AM IST

A big boost

Covaxin gets the stamp of international legitimacy

A big boost
Updated On : 03 Nov 2021 | 11:40 PM IST

G20 wants 70% of world vaccinated by mid-2022, sets up pandemic task force

The previous goal had eyed vaccinating 70 per cent of the world's population by the autumn of 2022

G20 wants 70% of world vaccinated by mid-2022, sets up pandemic task force
Updated On : 30 Oct 2021 | 2:31 AM IST

Govt extends nationwide containment measures till November 30

The home secretary said states and union territories, on a regular basis, should closely monitor case positivity, hospital, ICU beds occupancy of every district falling under their jurisdiction

Govt extends nationwide containment measures till November 30
Updated On : 29 Oct 2021 | 1:32 AM IST

Purchasing intention gets a boost as economy shows signs of recovery

Intentions to buy consumer products through Nykaa and Croma picked up pace

Purchasing intention gets a boost as economy shows signs of recovery
Updated On : 28 Oct 2021 | 1:07 AM IST

No nod for Bharat Bio's Covaxin yet, WHO seeks 'additional clarifications'

The technical advisory group will now meet on November 3 for a final assessment.

No nod for Bharat Bio's Covaxin yet, WHO seeks 'additional clarifications'
Updated On : 26 Oct 2021 | 11:50 PM IST

Over 1.03 billion vaccine doses administered in India so far, says govt

India's Covid-19 vaccination coverage has crossed 103 crore with over 51 lakh vaccine doses administered on Tuesday, the Union health ministry said

Over 1.03 billion vaccine doses administered in India so far, says govt
Updated On : 26 Oct 2021 | 10:43 PM IST

Checking in: Travel for business takes off again on a wing and a prayer

International business travel remains limited and is unlikely to get back to the pre-covid levels for some time yet

Checking in: Travel for business takes off again on a wing and a prayer
Updated On : 26 Oct 2021 | 6:08 AM IST